Early experience with remdesivir in SARS-CoV-2 pneumonia

At present, there is no definitive antiviral treatment for coronavirus disease 2019 (COVID-19). We describe our early experience with remdesivir in four critically ill COVID-19 patients. Patients received a 200 mg loading dose, followed by 100 mg daily intravenously for up to 10 days. All patients h...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Infection
Prif Awduron: Durante-Mangoni, Emanuele, Andini, Roberto, Bertolino, Lorenzo, Mele, Ferruccio, Florio, Letizia Lucia, Murino, Patrizia, Corcione, Antonio, Zampino, Rosa
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer Berlin Heidelberg 2020
Pynciau:
Case Report
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7229436/
https://ncbi.nlm.nih.gov/pubmed/32418190
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s15010-020-01448-x
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg